Digital Therapeutics Market Size, Share, Trends, Growth Opportunities, And Forecast, 2026-2035 AI And Value-Based Care Propel Market To USD 93.4 Billion

(MENAFN- GlobeNewsWire - Nasdaq) AI-led personalization, strategic partnerships, regulatory approvals, reimbursement expansion and clinical evidence are key to boosting adoption and ROI.

Dublin, Oct. 15, 2026 (GLOBE NEWSWIRE) -- "Digital Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering.

The Global Digital Therapeutics Market was valued at USD 9.6 billion in 2025 and is projected to reach USD 93.4 billion by 2035, expanding at a CAGR of 25.6% during the forecast period. Market growth is being driven by the rising prevalence of chronic health conditions, increasing healthcare expenditures, and growing demand for personalized, accessible, and cost-effective treatment options.

Healthcare systems are placing greater emphasis on preventive care, long-term patient monitoring, and outcome-based treatment models. This transition is accelerating the adoption of digital therapeutics across clinical and remote care settings. These solutions support continuous patient engagement, treatment adherence, and data-driven clinical decision-making while enabling healthcare organizations to deliver scalable interventions to broader patient populations.

Advances in artificial intelligence, machine learning, mobile health platforms, wearable technologies, and interactive digital engagement tools are improving the capabilities of digital therapeutics solutions. These technologies enable more personalized treatment pathways, stronger patient participation, and enhanced clinical outcomes. Expanding digital health infrastructure, improved connectivity, and wider acceptance of remote healthcare services are also supporting sustained market development.

Digital therapeutics are increasingly being integrated into healthcare delivery systems through clinically validated methodologies and regulatory-compliant platforms. Growing support from regulatory agencies and healthcare authorities is strengthening industry standards for safety, effectiveness, and quality. Clearer approval pathways and expanding clinical evidence are expected to increase confidence among healthcare providers, payers, and patients.

Software Segment Leads the Digital Therapeutics Market

The software segment accounted for 54.4% of the Global Digital Therapeutics Market in 2025. Its leading position is supported by widespread accessibility, compatibility with connected healthcare ecosystems, and increasing use of clinically validated digital treatment platforms.

Software-based solutions use patient-generated data, advanced analytics, behavioral science principles, and intelligent algorithms to create customized treatment pathways. These capabilities can strengthen treatment compliance, support long-term behavioral change, and improve chronic condition management. The scalability of software-driven therapeutics allows deployment across multiple digital devices and healthcare environments, extending access to populations that may have limited availability of conventional healthcare services.

Healthcare Providers Account for the Largest End-User Share

The healthcare providers segment captured 37.3% of the market in 2025. Hospitals, clinics, and other healthcare organizations are incorporating digital therapeutics into patient care pathways to improve monitoring, treatment effectiveness, and clinical outcomes.

Access to real-time patient insights, advanced analytics, and personalized intervention strategies enables clinicians to make more informed decisions and optimize treatment delivery. Adoption is also being supported by the growing availability of clinically validated and regulatory-compliant digital therapeutic solutions. Regulatory clearances and formal validation processes are increasing physician confidence, contributing to higher prescription and utilization rates.

North America Holds 58.1% Market Share

North America accounted for 58.1% of the Global Digital Therapeutics Market in 2025, making it the largest regional contributor. The region's substantial burden of chronic health conditions is generating strong demand for scalable, technology-enabled solutions that support personalized care and ongoing patient management.

Greater emphasis on preventive healthcare, remote monitoring, and value-based care models is encouraging adoption across the regional healthcare ecosystem. Employers are also incorporating digital health solutions into workforce wellness programs to support employee well-being, improve productivity, and reduce healthcare-related costs. This expansion beyond conventional clinical settings is creating additional opportunities for digital therapeutics providers.

Competitive Landscape and Growth Strategies

Key participants in the Global Digital Therapeutics Market include Teladoc Health, WellDoc, Omada Health, Kaia Health, Otsuka Holdings, Click Therapeutics, Virta Health, DarioHealth, Big Health, Sidekick Health, Orexo, Better Therapeutics, Akili Interactive, Propeller Health, and AmerisourceBergen.

Market participants are investing in research and development to strengthen clinical effectiveness, increase user engagement, and expand personalized treatment portfolios. Artificial intelligence, predictive analytics, and data-driven healthcare tools are becoming central to product differentiation and therapeutic optimization.

Strategic collaborations with healthcare providers, payers, technology companies, and research organizations are helping companies accelerate commercialization and broaden market access. Additional priorities include securing regulatory approvals, expanding reimbursement coverage, and generating robust clinical evidence to support physician confidence and adoption. Together, these strategies are expected to intensify competition and advance innovation across the Digital Therapeutics Market through 2035.

Comprehensive Market Analysis and Forecast

• Industry trends, key growth drivers, market challenges, future opportunities, and regulatory landscape
• Competitive landscape supported by Porter's Five Forces and PESTEL analysis
• Market size, segment performance, and regional forecasts through 2035
• In-depth company profiles, business strategies, financial insights, and SWOT analysis

Key Attributes:

Report Attribute	Details
No. of Pages	150
Forecast Period	2025 - 2035
Estimated Market Value (USD) in 2025	$9.6 Billion
Forecasted Market Value (USD) by 2035	$93.4 Billion
Compound Annual Growth Rate	25.6%
Regions Covered	Global

Key Topics Covered:
Chapter 1 Methodology and Scope
1.1 Research approach
1.2 Quality commitments
1.2.1 GMI AI policy & data integrity commitment
1.2.1.1 Source consistency protocol
1.3 Research trail & confidence scoring
1.3.1 Research trail components
1.3.2 Scoring components
1.4 Data collection
1.4.1 Partial list of primary sources
1.5 Data mining sources
1.5.1 Paid sources
1.5.1.1 Sources, by region
1.6 Base estimates and calculations
1.6.1 Base year calculation for any one approach
1.7 Forecast model
1.7.1 Quantified market impact analysis
1.7.1.1 Mathematical impact of growth parameters on forecast
1.8 Research transparency addendum
1.8.1 Source attribution framework
1.8.2 Quality assurance metrics
1.8.3 Our commitment to trust
Chapter 2 Executive Summary
2.1 Industry 360 synopsis
2.2 Key market trends
2.2.1 Business trends
2.2.2 Component trends
2.2.3 Application trends
2.2.4 End use trends
2.2.5 Regional trends
2.3 CXO perspectives: Strategic imperatives
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic disease
3.2.1.2 Rising demand for cost containment
3.2.1.3 Expansion of quality-of-care delivery
3.2.1.4 Growing popularity of digital therapeutics
3.2.2 Industry pitfalls and challenges
3.2.2.1 Data security and privacy concerns
3.2.2.2 Lack of skilled IT professionals
3.2.3 Market opportunities
3.2.3.1 Increasing shift toward preventive and value-based care
3.2.3.2 Expansion of combination therapy models
3.3 Growth potential analysis
3.4 Technology landscape (Driven by primary research)
3.4.1 Current technological trends
3.4.2 Emerging technologies
3.5 Regulatory landscape (Driven by primary research)
3.5.1 North America
3.5.2 Europe
3.5.3 Asia-Pacific
3.5.4 Latin America
3.5.5 Middle East and Africa
3.6 Porter's analysis
3.7 PESTEL analysis
3.8 Impact of AI and Generative AI on the market (Driven by primary research)
3.9 Investment & funding analysis
3.10 Future market trends
3.11 FDA-cleared digital therapeutics landscape
3.11.1 Limited FDA-cleared product availability
3.11.2 Key FDA-cleared products & players
3.11.3 Gap between wellness apps & regulated DTx
3.12 Reimbursement landscape
3.12.1 Payer coverage challenges
3.12.2 Employer-sponsored vs payer-reimbursed models
3.12.3 Germany DiGA reimbursement framework
Chapter 4 Competitive Landscape, 2025
4.1 Introduction
4.2 Company market share analysis (Driven by primary research)
4.2.1 North America
4.2.2 Europe
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
4.6.1 Merger and acquisition
4.6.2 Partnership and collaboration
4.6.3 New product launches
4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, by Component, 2022-2035 ($ Mn)
5.1 Key trends
5.2 Software
5.2.1 On-premises
5.2.2 Cloud-based
5.3 Hardware
5.3.1 Wearable devices
5.3.2 Sensors and monitoring devices
5.3.3 Other devices
5.4 Services
5.4.1 Consulting and integration
5.4.2 Training and education
5.4.3 Other services
Chapter 6 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
6.1 Key trends
6.2 Diabetes
6.3 Obesity
6.4 Cardiovascular
6.5 Mental & behavior health
6.6 Hypertension
6.7 Insomnia
6.8 Other applications
Chapter 7 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
7.1 Key trends
7.2 Healthcare providers
7.2.1 Hospitals
7.2.2 Clinics
7.2.3 Telehealth platforms
7.3 Payers
7.4 Patients
7.5 Other end users
Chapter 8 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia-Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Akili Interactive
9.2 AmerisourceBergen
9.3 Better Therapeutics
9.4 Big Health
9.5 Click Therapeutics
9.6 DarioHealth
9.7 Kaia Health
9.8 Omada Health
9.9 Orexo
9.10 Otsuka Holdings
9.11 Propeller Health
9.12 Sidekick Health
9.13 Teladoc Health
9.14 Virta Health
9.15 WellDoc
For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN15102026004107003653ID1111812767